In this episode of Medsider Radio, we had an awesome chat with Carla Spina, the pioneering force behind Noa Therapeutics. Carla and her team are developing treatments for inflammatory skin diseases with their innovative multimodal small-molecule therapies.

Carla began her academic journey at the University of Calgary in the fields of inorganic and analytical chemistry, and continued with a Ph.D. in Bioinorganic Chemistry at McGill University. After going to BASF in Germany to develop pharmaceutical formulations, Carla returned to Canada and led the development and global commercialization of antimicrobial wound care devices. Later, she also pioneered first-in-class pharmaceuticals for inflammatory and infectious skin diseases. Currently, she spearheads Noa Therapeutics, a Canadian biotech firm that is transforming how immune diseases are treated.

In this episode, Carla shares her invaluable experiences on the importance of engaging actively with the startup ecosystem and staying connected with those who are shaping the field. We talk about how building a company is a collaborative venture that requires a strong network of entrepreneurs, investors, and industry experts, and the significance of authentic interaction when reaching out to a variety of potential stakeholders.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We have also introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume IV. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Carla Spina.

Building a Startup in a Collaborative Ecosystem: Interview with Noa Therapeutics CEO Carla Spina

Medsider: Learn from Medtech and Healthtech Founders and CEOs

Building a Startup in a Collaborative Ecosystem: Interview with Noa Therapeutics CEO Carla Spina